WASHINGTON, April 14, 2016 /PRNewswire/ -- The World Orphan Drug Congress was conceptualized to provide a platform for pharma and biotech to come together and discuss ways to expedite orphan drug access to rare disease patients. Patient groups were already well-organized at that time but there were no groups organized specifically for industry.
We at Terrapinn saw this as important because although Orphan Drug Acts existed in US, Europe, Japan and Australia, the process from R&D to patient posed many challenges. Each year the conference brings together key industry stakeholders to discuss the latest strategies to overcome these challenges.
We now have over 700 registered with 206 from pharma/biotech and 113 patient groups. Register today at https://goo.gl/69FjiY to join them >
There is a lot going on at this year's event, so why not bring along your team! Take advantage of our group booking discount. Save 15% off each individual's ticket when you book online at https://goo.gl/69FjiY >
Attending Pharma/biotech include:
Abbvie – Abeona – Ablynx – Acer – Achillion – Advanced Imaging Projects – Aeglea – Agios – AGTC – Alexion – Alitair – Alnylam – Amarantus – Amicus – amryt – Anavex – ArmaGen – Astellas – aTyr – Audentes – BioBlast – Biogen Idec – BioMarin – Biopharm Solutions – Blueprint Medicines – Boehringer Ingelheim – Bristol Myers Squibb – ChemoCentryx – Chiesi – CMC Contrast – Concenter/Silkim - CuroNZ – Cytori – Dicerna – Eiger – Emmaus – Gem – Genesis – GSK – Glycomine – Greenovation – Grunenthal – GW – Heart Metabolics – Horizon – Hsiri – Incuron – Incyte – Infant Bacterial Therapeutics – Integene – Ipsen – Jupiter Orphan – Kadmon – Kamat – Kyowa Kirin – La Jolla – Lumos – Lung Biotechnology – Makindus – Marathon – Marinus – Mast – Medipost – Metrum Research Group – Mitsubishi Tanabe – Neem – Novartis – Nuvox – Opsona – Orig3n – Ovid – Patagonia – Pfizer – PhaseRx – Prana – Promet – ProQR – Prostrakan – Prothena – Psaydon – PTC Therapeutics – Puricore – QLT – QoL – Raptor – Reata – Recordati – RegenX – Respivert – Retrophin - Roche – Sancilio – SANO Molecular – Sanofi – Sarepta – Serendex – Shire – Sigma Tau – Silence – Singh – Siwa – Sixera – Spark – Therabron – Theravance – Thetis – Toleranzia – Turing – UCB – Ultragenyx – Valley Fever Solutions – Vanda – Wave Life Sciences – Zambon
Are you sure you want to miss out? http://goo.gl/S4MMRN >
Register today at https://goo.gl/69FjiY before you forget again just how beneficial these 3 days will be to your orphan drug approach. Take advantage of our group booking discount. Save 15% off each individual's ticket when you book online at https://goo.gl/69FjiY >
SOURCE Terrapinn Inc.